BridgeMD
New treatment option for Chronic Kidney Diseases
Official title Theory-based Health Behaviour Change Intervention in Patients of Metabolic Syndrome With Chronic Kidney Disease
ClinicalTrials.gov ID: NCT06527768
What this study is testing
- What it's testing
- The pilot study will adopt a 2-arm, pretest-posttest, and assessor-blind randomized controlled trial design to examine the feasibility and acceptability of a theory-based health behaviour change intervention and examine its effects on waist circumference (primary outcome), kidney function (estimated glomerular filtration rate, urine albumin-to-creatinine ratio, primary outcome), dietary behaviour, physical activity, exercise capacity and self-efficacy of diet behaviour and physical activity among Chinese adults with metabolic syndrome and chronic kidney disease. Researchers will compare the theory-based health behaviour change intervention to usual care to see if the theory-based health behaviour change intervention can reduce waist circumference and preserve kidney function over three months.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Participants are 18 years old and above;
- Participants have both diagnoses of MetS based on IDF clinical diagnostic criteria (WC for Chinese: ≥ 90 cm in men and ≥ 80 cm in women, and fulfils...
- No medical contraindications to exercise, including walking;
- Participants are capable of understanding and providing informed consent;
- Own a smartphone for accessing WeChat;
You likely can't join if
- Participants who cannot perform brisk walking exercise;
- Participants who have already started dialysis or kidney transplant;
- Current participation in another clinical trial related to health behaviour change or medical trial;
- Participants who have doctor-diagnosed psychiatric illness;
- Participants who have a cognitive impairment, which will be screened by the abbreviated mental test with a score lower than seven;
- Adjustment of medication within half a year;
See the full eligibility criteria
- Participants are 18 years old and above;
- Participants have both diagnoses of MetS based on IDF clinical diagnostic criteria (WC for Chinese: ≥ 90 cm in men and ≥ 80 cm in women, and fulfils two items of the following: TG ≥ 1.7 mmol/L or treatment for...
- No medical contraindications to exercise, including walking;
- Participants are capable of understanding and providing informed consent;
- Own a smartphone for accessing WeChat;
- Being able to communicate in Chinese;
- Stay in Chengdu during the study period.
- Participants who cannot perform brisk walking exercise;
- Participants who have already started dialysis or kidney transplant;
- Current participation in another clinical trial related to health behaviour change or medical trial;
- Participants who have doctor-diagnosed psychiatric illness;
- Participants who have a cognitive impairment, which will be screened by the abbreviated mental test with a score lower than seven;
- Adjustment of medication within half a year;
- Participants who have performed regular planned exercise (Defined as at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of high-intensity aerobic activity per week, or a combination of...
The study team makes the final eligibility decision.
Where it's taking place
- Chengdu, Sichuan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chengdu, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.